GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (XTER:FRE) » Definitions » Capex-to-Revenue

Fresenius SE KGaA (XTER:FRE) Capex-to-Revenue : 0.03 (As of Dec. 2023)


View and export this data going back to 1992. Start your Free Trial

What is Fresenius SE KGaA Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Fresenius SE KGaA's Capital Expenditure for the three months ended in Dec. 2023 was €-176.00 Mil. Its Revenue for the three months ended in Dec. 2023 was €5,678.00 Mil.

Hence, Fresenius SE KGaA's Capex-to-Revenue for the three months ended in Dec. 2023 was 0.03.


Fresenius SE KGaA Capex-to-Revenue Historical Data

The historical data trend for Fresenius SE KGaA's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Capex-to-Revenue Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Capex-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.09 0.08 0.06 0.05

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.05 0.04 0.04 0.02 0.03

Competitive Comparison of Fresenius SE KGaA's Capex-to-Revenue

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Capex-to-Revenue Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Capex-to-Revenue falls into.



Fresenius SE KGaA Capex-to-Revenue Calculation

Fresenius SE KGaA's Capex-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-1134) / 22299
=0.05

Fresenius SE KGaA's Capex-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-176) / 5678
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fresenius SE KGaA  (XTER:FRE) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Fresenius SE KGaA Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (XTER:FRE) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.
Executives
Dr. Michael Moser Board of Directors
Sara Hennicken Board of Directors
Michael Sen Board of Directors
Dr. Francesco De Meo Board of Directors
Stephan Sturm Board of Directors
Wolfgang Kirsch Supervisory Board
Mats Henriksson Board of Directors
Dr. Gerd Krick Supervisory Board

Fresenius SE KGaA (XTER:FRE) Headlines

No Headlines